cannabidiol
Showing 51 - 75 of 91
Lennox Gastaut Syndrome, Dravet Syndrome, Tuberous Sclerosis Complex Trial in United States (Cannabidiol)
Recruiting
- Lennox Gastaut Syndrome
- +2 more
- Cannabidiol
-
Downey, California
- +30 more
Aug 4, 2022
Dual Diagnosis Trial in Glostrup (Cannabidiol, Risperidone)
Recruiting
- Dual Diagnosis
- Cannabidiol
- Risperidone
-
Glostrup, DenmarkCenter for Neuropsychiatric Schizophrenia Research
Jun 7, 2021
Sturge-Weber Syndrome Trial in Baltimore (Cannabidiol)
Completed
- Sturge-Weber Syndrome
- Cannabidiol
-
Baltimore, MarylandKennedy Krieger Institute
Feb 14, 2022
Opioid Use Disorder Trial in Aurora (Cannabidiol, Placebo)
Recruiting
- Opioid Use Disorder
- Cannabidiol
- Placebo
-
Aurora, Colorado
- +1 more
Mar 17, 2022
Alcohol Use Disorder Trial in Aurora (Cannabidiol, Placebo)
Recruiting
- Alcohol Use Disorder
- Cannabidiol
- Placebo
-
Aurora, ColoradoUniversity of Colorado Denver
Feb 22, 2022
Breast Cancer Female Trial (All trans-retinoic acid, 13-Cis Retinoic Acid plus Tocopherol, Mifepristone)
Not yet recruiting
- Breast Cancer Female
- All trans-retinoic acid
- +6 more
- (no location specified)
Aug 17, 2021
Schizophrenia Trial in Denmark, Germany (Cannabidiol, Olanzapine, Placebo Cannabidiol)
Active, not recruiting
- Schizophrenia
- Cannabidiol
- +3 more
-
Glostrup, Denmark
- +5 more
Apr 26, 2021
Anxiety Trial (Cannabidiol)
Withdrawn
- Anxiety
- Cannabidiol
- (no location specified)
Dec 17, 2020
COVID-19 Trial in Petach Tikva (Cannabidiol)
Unknown status
- COVID-19
- Cannabidiol
-
Petach Tikva, IsraelRabin Medical Center
Jan 28, 2021
Drug Resistant Epilepsy Trial in Jackson (Cannabidiol)
Available
- Drug Resistant Epilepsy
- Cannabidiol
-
Jackson, MississippiUniversity of Mississippi Medical Center
Nov 12, 2020
Substance Use Disorder, Cocaine Dependence, Withdrawal From Addictive Substance; Detoxification Trial in Montreal (Cannabidiol)
Completed
- Substance Use Disorder
- +2 more
- Cannabidiol
-
Montreal, Quebec, CanadaCentre de recherche du Centre Hospitalier de l'Université de Mon
Oct 21, 2020
Dravet Syndrome, Lennox Gastaut Syndrome Trial in Seoul (Cannabidiol)
Unknown status
- Dravet Syndrome
- Lennox Gastaut Syndrome
- Cannabidiol
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University College of Medicine
Oct 26, 2020
Psoriatic Arthritis, Hand Osteoarthritis Trial in Aalborg (Cannabidiol, Placebo Oral Tablet)
Completed
- Psoriatic Arthritis
- Hand Osteoarthritis
- Cannabidiol
- Placebo Oral Tablet
-
Aalborg, DenmarkDepartment of Rheumatology Aalborg Universityhospital North
Jul 3, 2021
Prader-Willi Syndrome Trial in United States (Cannabidiol, Placebo)
Terminated
- Prader-Willi Syndrome
- Cannabidiol
- Placebo
-
Tucson, Arizona
- +6 more
Nov 11, 2020
Pharmacokinetics, Bioavailability Trial in Cologne (Cannabidiol)
Terminated
- Pharmacokinetics, Bioavailability
- Cannabidiol
-
Cologne, GermanyDepartment I of Pharmacology, University of Cologne
Jun 29, 2020
Autoimmune Hepatitis Trial in Petach Tikva (Cannabidiol)
Terminated
- Autoimmune Hepatitis
- Cannabidiol
-
Petach Tikva, IsraelBelinson Medical Center
Jun 14, 2020
Crohn Disease, IBD, Cannabis Trial (Cannabidiol, Placebo oral capsule)
Withdrawn
- Crohn Disease
- +2 more
- Cannabidiol
- Placebo oral capsule
- (no location specified)
Mar 23, 2020
Alcohol Withdrawal, Alcohol Dependence Trial in Sydney (Cannabidiol, Placebo)
Unknown status
- Alcohol Withdrawal
- Alcohol Dependence
- Cannabidiol
- Placebo
-
Sydney, New South Wales, Australia
- +1 more
Jan 6, 2020
Epilepsy Trial in Salt Lake City (Cannabidiol)
Completed
- Epilepsy
- Cannabidiol
-
Salt Lake City, UtahUniversity of Utah School of Medicine
Jan 24, 2020
Alcohol Use Disorder Trial in Charleston (Cannabidiol, Placebo)
Withdrawn
- Alcohol Use Disorder
- Cannabidiol
- Placebo
-
Charleston, South CarolinaMedical University of South Carolina
Oct 9, 2019
Drug Addiction Trial in Chicago (Cannabidiol, Placebo)
Completed
- Drug Addiction
- Cannabidiol
- Placebo
-
Chicago, IllinoisUniversity of Chicago
Aug 26, 2019
Schizophrenia Trial in Utrecht (Placebo, Cannabidiol)
Completed
- Schizophrenia
- Placebo
- Cannabidiol
-
Utrecht, NetherlandsUniversity Medical Center Utrecht
Mar 26, 2020
Epilepsy Trial (Cannabidiol)
Approved for marketing
- Epilepsy
- Cannabidiol
- (no location specified)
May 27, 2019
Healthy Volunteers, Modeling Psychosis Trial in Mannheim (Delta-9-tetrahydrocannabinol, Cannabidiol, Placebo)
Unknown status
- Healthy Volunteers
- Modeling Psychosis
- Delta-9-tetrahydrocannabinol
- +2 more
-
Mannheim, BW, GermanyCentral Institute of Mental Health
Aug 12, 2019